# FDA recall D-0143-2023

> **Akorn, Inc.** · Class II · drug recall initiated 2022-10-13.

## Product

Lidocaine Hydrochloride Jelly USP, 2%, Packaged as (a) 5 mL tube (NDC 17478-711-10) x10 per box NDC 17478-711-31; (b) 30 mL tube NDC 17478-711-30; Rx only,  Manufactured by: Akorn, Inc., Lake Forest, Il 60045.

## Reason for recall

CGMP Deviations:

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0143-2023
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2022-10-13
- **Report date:** 2023-01-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Gurnee, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0143-2023

## Citation

> AI Analytics. FDA recall D-0143-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0143-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*